Skip to main content
Premium Trial:

Request an Annual Quote

TIGR, Biolog Pen Phenotype-Microarray R&D Collaboration

NEW YORK, Oct. 1 - Biolog today said it has licensed its new phenotype microarray technology to The Institute for Genomic Research.

 

TIGR will use the technology, with Biolog's help, "to understand and characterize" phenotypes of different bacterial strains, especially strains of Salmonella typhimurium, Streptococcus pneumoniae, Staphylococcus aureus, Synechococcus sp. and Escherichia coli.

The institute said it will conduct in-house comparative-genomics and microarray studies to interpret the data that come out of the collaboration.

 

Under the terms of the agreement, TIGR and Biolog will share certain undisclosed IP rights from any new discoveries identified using the PM technology. The partners have also agreed to exclusively license any discoveries that might have potential commercial applications.

 

"We hope to be able to complement our existing genome sequencing, bioinformatic and expression microarray capabilities with Biolog's phenotype microarray technology to further our understanding of microbial cell function," said Ian Paulsen, the TIGR faculty member leading the phenotype microarray analyses.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.